CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
983
Frequently Asked Questions
What is Market Cap of CureVac N.V.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. CureVac N.V. market cap is $1.21B.
What is the 52-week high for CureVac N.V.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. CureVac N.V. 52 week high is $5.72 as of September 09, 2025.
What is the 52-week low for CureVac N.V.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. CureVac N.V. 52 week low is $2.37 as of September 09, 2025.
What is CureVac N.V. stock price today?
CureVac N.V. stock price today is $5.35.
What was CureVac N.V. stock price yesterday?
CureVac N.V. stock price yesterday was $5.39.
What is the PE ratio of CureVac N.V.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. CureVac N.V.’s P/E ratio is 5.94.
What is the Price-to-Book ratio of CureVac N.V.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. CureVac N.V. P/B ratio is 1.7373.
What is the 50-day moving average of CureVac N.V.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. CureVac N.V. 50-day moving average is $5.43.
